The developmental biology of brain tumors

Annual Review of Neuroscience

Volumn 24, Issue , 2001, Pages 385-428

  Wechsler Reya, R ^a   Scott, M P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Development; Glioblastoma; Medulloblastoma; Retinoblastoma

Indexed keywords

ANIMAL CELL; APOPTOSIS; BRAIN TUMOR; CELL DIFFERENTIATION; CELL TYPE; CENTRAL NERVOUS SYSTEM TUMOR; DEVELOPMENTAL BIOLOGY; GLIOBLASTOMA; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; RETINA DEVELOPMENT; RETINOBLASTOMA; REVIEW; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CEREBELLAR NEOPLASMS; CHILD; EYE NEOPLASMS; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HUMANS; MEDULLOBLASTOMA; RETINOBLASTOMA;

EID: 0034927062     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.neuro.24.1.385     Document Type: Review

References (320)

1. Cell cycle arrest and astrocytic differentiation resulting from PTEN expression in glioma cells
2. Expression of necdin, an embryonal carcinoma-derived nuclear protein, in developing mouse brain
3. Mutational spectra of PETEN/MMAC1 gene: A tumor suppressor with lipid phosphatase activity
4. Proliferation and migration of undifferentiated precursor cells in the rat during postnatal gliogenesis
5. Bilateral retinal and brain tumors in transgenic mice expressing simian virus 40 large T antigen under control of the human interphotoreceptor retinoid-binding protein promoter
6. Astrocyte-induced modulation of synaptic transmission
7. Early response gene induction in astrocytes as a mechanism for encoding and integrating neuronal signals
8. Astrocytes as mediators of immune and inflammatory responses in the CNS
9. Ultraviolet and ionizing radiation enhance the growth of BCCs and trichoblastomas in patched heterozygous knockout mice
10. The transcription factor E2F-1 in SV40 T antigen-induced cerebellar Purkinje cell degeneration
11. Vertebrate retinal ganglion cells are selected from competent progenitors by the action of Notch
12. The role of glial cells in synaptic function
13. Localization and characterization of PACAP receptors in the rat cerebellum during development: Evidence for a stimulatory effect of PACAP on immature cerebellar granule cells
14. p14ARF links the tumour suppressors RB and p53
15. Nonrandom chromosomal changes in untreated retinoblastomas
16. Growth and fate of PSA-NCAM+ precursors of the postnatal brain
17. The history of radial glia
18. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis
19. Mutations of TP53, amplification of EGFR, MDM2 and CDK4, and deletions of CDKN2A in malignant astrocytomas
20. Chromosomal characteristics of childhood brain tumors
21. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway
22. Genetics of embryonal tumours of childhood: Retinoblastoma, Wilms' tumour and neuroblastoma
23. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
24. Ocular retardation mouse caused by Chx10 homeobox null allele: Impaired retinal progenitor proliferation and bipolar cell differentiation
25. Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system
26. Mechanisms of progenitor maturation are conserved in the striatum and cortex
27. Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas
28. Neural precursor cells differentiating in the absence of Rb exhibit delayed terminal mitosis and deregulated E2F 1 and 3 activity
29. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
30. Regulation of cell death protease caspase-9 by phosphorylation
31. The roles of intrinsic and extrinsic cues and bHLH genes in the determination of retinal cell fates
32. In vivo evidence that patched and smoothened constitute distinct binding and transducing components of a Hedgehog receptor complex
33. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes
34. A novel gene, LGI1, from 10q24 is rearranged and downregulated in malignant brain tumors
35. The INK4a/ARF tumor suppressor: One gene-two products-two pathways
36. Requirement for a functional Rb-1 gene in murine development
37. Tumor suppressor genes and medulloblastoma
38. Gliomas
39. Inhibition of glycogen synthase kinase 3-beta activity regulates proliferation of cultured cerebellar granule cells
40. Bone morphogenetic proteins induce differentiation in astrocyte lineage cells
41. Expression patterns of the E2F family of transcription factors during mouse nervous system development
42. Sonic hedgehog regulates the growth and patterning of the cerebellum
43. Sonic hedgehog-induced activation of the Gli1 promoter is mediated by GLI3
44. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
45. Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis
46. A self-renewing multipotential stem cell in embryonic rat cerebral cortex
47. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene
48. Distinct roles for E2F proteins in cell growth control and apoptosis
49. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas
50. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
51. Impaired Fas response and autoimmunity in Pten+/- mice
52. The multiple roles of PTEN in tumor suppression
53. Pten is essential for embryonic development and tumour suppression
54. Constitutive overexpression of CDK2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells
55. Apoptosis induced by the nuclear death domain protein p84N5 is inhibited by association with Rb protein
56. Mechanisms and consequences of activation of protein kinase B/Akt
57. Genetic sequences that predispose to retinoblastoma and osteosarcoma
58. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
59. Nuclear localization and mutation of beta-catenin in medulloblastomas
60. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo
61. Functional characterization of an EGF receptor with a truncated extracellular domain expressed in glioblastomas with EGFR gene amplification
62. Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails
63. Regulation of p53 downstream genes
64. Loss of heterozygosity in the VNTR region of intron 1 of P53 in two retinoblastoma cases
65. Involvement of wound-associated factors in rat brain astrocyte migratory response to axonal injury: In vitro simulation
66. In vivo viability of postmitotic Purkinje neurons requires pRb family member function
67. Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice
68. Susceptibility to cell death induced by mutant SV40 T-antigen correlates with Purkinje neuron functional development
69. E2F-1 functions in mice to promote apoptosis and suppress proliferation
70. Two MAD tails: What the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network
71. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
72. Targeting in gene therapy for gliomas
73. Suppression of human glioma growth by adenovirus-mediated Rb gene transfer
74. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme
75. Structural evidence for the authenticity of the human retinoblastoma gene
76. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells
77. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain
78. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells
79. p300 and CBP: Partners for life and death
80. Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene
81. Gene therapy for gliomas: p53 and E2F-1 proteins and the target of apoptosis
82. Pituitary adenylate cyclase-activating polypeptide promotes cell survival and neurite outgrowth in rat cerebellar neuroblasts
83. Altered neural cell fates and medulloblastoma in mouse patched mutants
84. Hedgehog and patched in neural development and disease
85. Nevoid basal-cell carcinoma syndrome
86. Multiple genetic loci modify risk for retinoblastoma in transgenic mice
87. Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells
88. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN
89. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC
90. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome
91. The patched signaling pathway in tumorigenesis and development: Lessons from animal models
92. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome
93. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA
94. Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression
95. The molecular basis of Turcot's syndrome
96. The world according to Hedgehog
97. In vitro neurite extension by granule neurons is dependent upon astroglial-derived fibroblast growth factor
98. Mechanisms of glial-guided neuronal migration in vitro and in vivo
99. Arrest of cell growth by necdin, a nuclear protein expressed in postmitotic neurons
100. The role of the epidermal growth factor receptor in human gliomas: I. The control of cell growth
101. The role of the epidermal growth factor receptor in human gliomas: II. The control of glial process extension and the expression of glial fibrillary acidic protein
102. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice
103. Cellular determination in the Xenopus retina is independent of lineage and birth date
104. Apoptosis or retinoblastoma: Alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53
105. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction
106. APC mutations in sporadic medulloblastomas
107. Ciliary neurotrophic factor induces type-2 astrocyte differentiation in culture
108. Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities
109. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene
110. Effects of an Rb mutation in the mouse
111. The retinoblastoma gene family is differentially expressed during embryogenesis
112. Human homolog of patched, a candidate gene for the basal cell nevus syndrome
113. Neonatal cerebellar medulloblastoma originating from the fetal external granular layer
114. Neuroepithelial stem cells from the embryonic spinal cord: Isolation, characterization, and clonal analysis
115. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
116. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina
117. Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma
118. Signal transduction by bone morphogenetic proteins
119. EGF receptor in neoplasia and metastasis
120. NRP/B, a novel nuclear matrix protein, associates with p110 (RB) and is involved in neuronal differentiation
121. Structure, expression and function of a schwannoma-derived growth factor
122. Mutation and cancer: Statistical study of retinoblastoma
123. Mutation and childhood cancer: A probabilistic model for the incidence of retinoblastoma
124. Neural precursor differentiation into astrocytes requires signaling through the leukemia inhibitory factor receptor
125. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4
126. Distinct modes of neuronal migration in different domains of developing cerebellar cortex
127. Direct control of the Forkhead transcription factor AFX by protein kinase B
128. Abnormal astrocyte development and neuronal death in mice lacking the epidermal growth factor receptor
129. Multiple trophic actions of heparin-binding epidermal growth factor (HB-EGF) in the central nervous system
130. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2
131. Deregulated expression of PAX5 in medulloblastoma
132. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile
133. Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells
134. Similar chromosomal abnormalities in several retinoblastomas
135. Retinoblastoma - Origin from a primitive neuroectodermal cell?
136. Retinoblastoma: A primitive tumor with multipotential characteristics
137. Adenovirus-mediated p53 gene therapy for human gliomas
138. Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene
139. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
140. Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation
141. Gliogenesis in the central nervous system
142. Neuronal Cdc2-like kinase (Nc1k) binds and phosphorylates the retinoblastoma protein
143. Neuronal Cdc2-like kinases: Neuron-specific forms of Cdk5
144. Targeted disruption of p107: Functional overlap between p107 and Rb
145. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence
146. Cognitive and language functions of the human cerebellum
147. Epidermal growth factor stimulates DNA-synthesis of astrocytes in primary cerebellar cultures
148. Soluble factors and the development of rod photoreceptors
149. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta
150. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene
151. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
152. A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast
153. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
154. Amplification and overexpression of the EGF receptor gene in primary human glioblastomas
155. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin
156. Changes in retinal cell fate induced by overexpression of EGF receptor
157. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: Relationship to prognostic significance
158. The retinoblastoma gene family in differentiation and development
159. Histopathology, immunochemistry and ultrastructure of brain tumors
160. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells
161. Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium
162. Viral oncoprotein binding to pRB, p107, p130, and p300
163. Neurons, astrocytes, and oligodendrocytes of the rate cerebral cortex originate from separate progenitor cells: An ultrastructural analysis of clonally related cells
164. Expression of LKB1 and PTEN tumor suppressor genes during mouse embryonic development
165. Bone morphogenetic proteins induce astroglial differentiation of oligodendroglial-astroglial progenitor cells
166. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system
167. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
168. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation
169. Germline mutations in PTEN are present in Bannayan-Zonana syndrome
170. PKB/Akt: Connecting phosphoinositide 3-kinase to cell survival and beyond
171. Glia, neurons, and axon pathfinding during optic chiasm development
172. The Rx homeobox gene is essential for vertebrate eye development
173. Regulation of eye formation by the Rx and pax6 homeobox genes
174. Development of Purkinje cell bodies and processes with basic fibroblast growth factor-like immunoreactivity in the rat cerebellum
175. Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells
176. The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain
177. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
178. Bone morphogenetic proteins in the nervous system
179. Developmental changes in progenitor cell responsiveness to bone morphogenetic proteins differentially modulate progressive CNS lineage fate
180. Purification and characterization of astrocyte precursor cells in the developing rat optic nerve
181. A role for En-2 and other murine homologues of Drosophila segment polarity genes in regulating positional information in the developing cerebellum
182. Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas
183. DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer
184. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours
185. Astrocytes: Form, functions, and roles in disease
186. Cerebellar mutant mice and chimeras revisited
187. The lipid phosphatase activity of PTEN is critical for its tumor supressor function
188. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase
189. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases
190. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region
191. Developmental requirement of gp 130 signaling in neuronal survival and astrocyte differentiation
192. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300
193. Astrocyte differentiation mediated by LIF in cooperation with BMP2
194. Protein tyrosine phosphatases in signal transduction
195. Cell cycle targets of the DNA tumor viruses
196. Role of the Rb/E2F pathway in cell growth control
197. Expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the postnatal and adult rat cerebellar cortex
198. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation
199. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity
200. From rodent glial precursor cell to human glial neoplasia in the oligodendrocyte-type-2 astrocyte lineage
201. Retinoblastoma. Cell of origin
202. U.S. childhood cancer survival, 1973-1987
203. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome
204. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy
205. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein
206. Bipotent cortical progenitor cells process conflicting cues for neurons and glia in a hierarchical manner
207. Primary degeneration of the granular layer of the cerebellum. A study of 14 patients and review of the literature
208. Wnt signaling in oncogenesis and embryogenesis - A look outside the nucleus
209. Determination of vertebrate retinal progenitor cell fate by the Notch pathway and basic helix-loop-helix transcription factors
210. Role of target antigen in bispecific-antibody-mediated killing of human glioblastoma cells: A preclinical study
211. New views on synapse-glia interactions
212. Induction of DNA synthesis and apoptosis are separable functions of E2F-1
213. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched
214. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ system
215. The oncogenic activation of beta-catenin
216. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
217. Chromosomal abnormalities in human retinoblastoma: A review
218. Mechanisms of astrocyte-directed neurite guidance
219. The type 1 (EGFR-related) family of growth factor receptors and their ligands
220. Dorsal spinal cord neuroepithelium generates astrocytes but not oligodendrocytes
221. Inhibitory effect of antisense epidermal growth factor receptor RNA on the proliferation of rat C6 glioma cells in vitro and in vivo
222. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis
223. Multiple functions for Pax6 in mouse eye and nasal development
224. Lineage restriction of neuroepithelial precursor cells from fetal human spinal cord
225. A role for transforming growth factor alpha as an inducer of astrogliosis
226. Sporadic medulloblastomas contain PTCH mutations
227. Multiple routes to astrocytic differentiation in the CNS
228. Regulation of G1 progression by the PTEN tumor suppressor protein in linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway
229. Multipotent and restricted precursors in the central nervous system
230. Glial-restricted precursors are derived from multipotent neuroepithelial stem cells
231. A tripotential glial precursor cell is present in the developing spinal cord
232. Genetic alterations in glioma and medulloblastoma
233. Loss of heterozygosity for 10q loci in human gliomas
234. Molecular pathogenesis of malignant gliomas
235. Cellular interactions determine neuronal phenotypes in rodent retinal cultures
236. Age of differentiation determines rat retinal germinal cell phenotype: Induction of differentiation by dissociation
237. Multipotential stem cells and progenitors in the vertebrate retina
238. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes
239. Ciliary neurotrophic factor: A review
240. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta
241. p107 is a suppressor of retinoblastoma development in pRb-deficient mice
242. Development of the mammalian retina
243. Catching a Gli-mpse of Hedgehog
244. Expression of a dominant negative FGF receptor inhibits axonal growth and FGF receptor phosphorylation stimulated by CAMs
245. Glioblastoma and malignant astrocytoma
246. Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: Implication of Gli2 and Gli3 as primary mediators of Shh signaling
247. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas
248. Repression by the Mad(Mxi1)-Sin3 complex
249. Interfering with the pathologic activation of microglial cells and astrocytes in dementia
250. Intracellular signaling pathways activated by neurotrophic factors
251. Isolation, cloning and characterization of a putative type-1 astrocyte cell line
252. Expression of oligodendrocyte progenitor cell antigens by gliomas: Implications for the histogenesis of brain tumors
253. Structure and function of human amphiregulin: A member of the epidermal growth factor family
254. A strain-independent postnatal neurodegeneration in mice lacking the EGF receptor
255. Strain-dependent epithelial defects in mice lacking the EGF receptor
256. Functional evidence for a role of combined CDKN2A (p16-p14(ARF))/CDKN2B (p15) gene inactivation in malignant gliomas
257. Epidermal growth factor binding and mitogenic activity on purified populations of cells from the central nervous system
258. Pituitary adenylate cyclase activating polypepetide is expressed by developing rat Purkinje cells and decreases the number of cerebellar gamma-amino butyric acid positive neurons in culture
259. A critical temporal requirement for the retinoblastoma protein family during neuronal determination
260. Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells
261. Cells differentiating into neuroectoderm undergo apoptosis in the absence of functional retinoblastoma family proteins
262. Local control of granule cell generation by cerebellar Purkinje cells
263. Cell cycle regulation of the transcriptional coactivators p300 and CREB binding protein
264. Molecular analysis of two putative tumour suppressor genes, PTEN and DMBT, which have been implicated in glioblastoma multiforme disease progression
265. A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma
266. Modulation of cellular apoptotic potential: Contributions to oncogenesis
267. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
268. Functional and molecular analyses of 10q deletions in human gliomas
269. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers
270. Gliogenesis in the prenatal rabbit spinal cord
271. A quantitative histological study of cell division and changes in cell number in the meningeal sheath of the embryonic human optic nerve
272. Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas
273. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5-trisphosphate and Akt/protein kinase B signaling pathway
274. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
275. Photoreceptor differentiation of retinoblastoma: An electron microscopic study of 29 retinoblastomas
276. Regulation of nuclear translocation of Forkhead transcription factor AFX by protin kinase B
277. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway
278. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN
279. PTEN gene and integrin signaling in cancer
280. Neuronal Cdc2-like kinase: From cell cycle to neuronal function
281. Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators
282. Long-term culture of purified postnatal oligodendrocyte precursor cells: Evidence for an intrinsic maturation program that plays out over months
283. Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1
284. Neurogenetics and the molecular biology of human brain tumors
285. Swaying is a mutant allele of the proto-oncogene Wnt-1
286. Targeted disruption of mouse EGF receptor: Effect of genetic background on mutant phenotype
287. Antisense epidermal growth factor receptor RNA transfection in human malignant glioma cells leads to inhibition of proliferation and induction of differentiation
288. Restoration of wild-type PTEN expression leads to apoptosis, induces differentiation, and reduces telomerase activity in human glioma cells
289. From form to function: Signaling by protein tyrosine phosphatases
290. Signaling mechanisms of cytokine receptors and their perturbances in disease
291. Regional distribution of Sonic hedgehog, patched, and smoothened mRNA in the adult rat brain
292. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos
293. Differentiation of human retinoblastoma in vitro into cell types with characteristics observed in embryonal or mature retina
294. Lineage-independent determination of cell type in the embryonic mouse retina
295. Differential neurite growth on astrocyte substrates: Interspecies facilitation in green fluorescent protein-transfected rat and human neurons
296. The highly integrated dialogue between neurons and astrocytes in brain function
297. Purkinje-cell-derived Sonic hedgehog regulates granule neuron precursor cell proliferation in the developing mouse cerebellum
298. Rod photoreceptor development in vitro: Intrinsic properties of proliferating neuroepithelial cells change as development proceeds in the rat retina
299. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells
300. Control of neuronal precursor proliferation in the cerebellum by Sonic hedgehog
301. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis
302. Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells
303. The normal patched allele is expressed in medulloblastomas from mice with heterozygous germ-line mutation of patched
304. Cell lineage analysis reveals multipotent precursors in the ciliary margin of the frog retina
305. Association between an oncogene and an antioncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product
306. Mechanisms of Wnt signaling in development
307. Structural alterations of the epidermal growth factor receptor gene in human gliomas
308. Transcriptional activation of p21WAF1 by PTEN/MMAC1 tumor suppressor
309. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2
310. p53 and E2F-1 cooperate to mediate apoptosis
311. Mutations of the Patched gene in several types of sporadic extracutaneous tumors
312. Role of cyclins in neuronal differentiation of immortalized hippocampal cells
313. Predominant expression of human zic in cerebellar granule cell lineage and medulloblastoma
314. The APC gene in Turcot's syndrome
315. Cell cycle regulators in neural stem cells and postmitotic neurons
316. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
317. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection
318. Sporadic medulloblastomas contain oncogenic beta-catenin mutations